4//SEC Filing
AVEO PHARMACEUTICALS INC 4
Accession 0001209191-17-023492
CIK 0001325879operating
Filed
Mar 28, 8:00 PM ET
Accepted
Mar 29, 4:11 PM ET
Size
5.5 KB
Accession
0001209191-17-023492
Insider Transaction Report
Form 4
Sakoda Jon
10% Owner
Transactions
- Purchase
Common Stock
2017-03-28$0.50/sh+6,000,000$3,000,000→ 16,362,694 total(indirect: See Note 2)
Footnotes (2)
- [F1]Reports the purchase of shares in the underwritten public offering of common stock of AVEO Pharmaceuticals, Inc.
- [F2]The Reporting Person is a manager of NEA 15 GP, LLC, ("NEA 15 GP") which is the sole general partner of NEA Partners 15, L.P. ("NEA Partners 15"). NEA Partners 15 is the sole general partner of New Enterprise Associates 15, L. P. ("NEA 15"). NEA 15 is the sole member of Growth Equity Opportunities Fund IV, LLC ("GEO IV"), which is the direct beneficial owner of the shares. The Reporting Person disclaims beneficial ownership within the meaning of Section 16 of the Securities Exchange Act of 1934, as amended, or otherwise of such portion of the shares held by GEO IV in which the Reporting Person has no pecuniary interest.
Documents
Issuer
AVEO PHARMACEUTICALS INC
CIK 0001325879
Entity typeoperating
Related Parties
1- filerCIK 0001325879
Filing Metadata
- Form type
- 4
- Filed
- Mar 28, 8:00 PM ET
- Accepted
- Mar 29, 4:11 PM ET
- Size
- 5.5 KB